论文部分内容阅读
目的 :探讨中西医结合“序贯治疗”对不稳定型冠状动脉疾病 (U CAD)的临床疗效。方法 :选择 42例UCAD住院患者为治疗组与同期 86例住院患者为对照组。对照组按西医常规治疗 ,治疗组在此基础上给予降纤酶、“神农益气活血”注射液 2 0 0 ml静滴治疗 ,每日 2次 ,共 7～ 10日。结果 :治疗组患者症状缓解率、心电图好转率、急性心肌梗死 (AMI)发生率及病死率均显著优于对照组 (P<0 .0 5 )。心肌酶同工酶 (CK MB)、纤维蛋白原、凝血酶原时间、部分凝血活酶时间及血小板聚集率均显著低于对照组 (P<0 .0 1)。结论 :中西医结合“序贯治疗”对 UCAD疗效显著 ,优于常规治疗
Objective: To explore the clinical efficacy of “sequential treatment” of integrated traditional Chinese and western medicine on unstable coronary artery disease (U CAD). Methods: 42 UCAD hospitalized patients were selected as treatment group and 86 hospitalized patients as control group. The control group was routinely treated by western medicine. On the basis of this, the treatment group was treated with defibrase, Shennong Yiqi Huoxue Injection 200 ml intravenously, twice a day for 7-10 days. Results: The symptom relief rate, electrocardiogram improvement rate, acute myocardial infarction (AMI) incidence and mortality in the treatment group were significantly better than those in the control group (P <0.05). CK MB, fibrinogen, prothrombin time, partial thromboplastin time and platelet aggregation rate were significantly lower than the control group (P <0.01). Conclusion: The combination of TCM and Western medicine “sequential treatment” has a significant effect on UCAD, superior to conventional treatment